Continuous subcutaneous apomorphine infusions for fluctuating Parkinson's disease. Long-term follow-up in 18 patients
Affiliations
- PMID: 8420206
Item in Clipboard
Continuous subcutaneous apomorphine infusions for fluctuating Parkinson's disease. Long-term follow-up in 18 patients
Adv Neurol.
1993.
No abstract available
Similar articles
-
Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years.Mov Disord. 1993 Apr;8(2):165-70. doi: 10.1002/mds.870080208. Mov Disord. 1993. PMID: 8474483
-
[Apomorphine test in Parkinson disease--dose and corresponding parameters].Wien Klin Wochenschr. 1993;105(16):472-5. Wien Klin Wochenschr. 1993. PMID: 8212705 German.
-
Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.Mov Disord. 2002 Nov;17(6):1235-41. doi: 10.1002/mds.10281. Mov Disord. 2002. PMID: 12465062
-
Dystonia and Parkinson's disease.Adv Neurol. 1993;60:558-61. Adv Neurol. 1993. PMID: 8420191 Review. No abstract available.
-
Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management.Expert Rev Neurother. 2009 Jun;9(6):859-67. doi: 10.1586/ern.09.48. Expert Rev Neurother. 2009. PMID: 19496689 Review.
Cited by
-
Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.Drugs Aging. 2004;21(11):687-709. doi: 10.2165/00002512-200421110-00001. Drugs Aging. 2004. PMID: 15323576 Review.
-
Advanced stages of PD: interventional therapies and related patient-centered care.J Neural Transm (Vienna). 2016 Jan;123(1):31-43. doi: 10.1007/s00702-015-1418-0. Epub 2015 Jul 3. J Neural Transm (Vienna). 2016. PMID: 26138439 Review.
-
Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.Biol Psychiatry. 2017 Jan 1;81(1):67-77. doi: 10.1016/j.biopsych.2015.12.028. Epub 2016 Jan 18. Biol Psychiatry. 2017. PMID: 26946382 Free PMC article. Review.
-
What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?J Neural Transm (Vienna). 2011 Jun;118(6):907-14. doi: 10.1007/s00702-010-0555-8. Epub 2010 Dec 25. J Neural Transm (Vienna). 2011. PMID: 21188435 Review.
-
Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1998 May;64(5):573-6. doi: 10.1136/jnnp.64.5.573. J Neurol Neurosurg Psychiatry. 1998. PMID: 9598668 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical